13F-HR filed by CHI Advisors LLC
CHI Advisors LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-13, with 23 holding rows worth $375,461,657.
- Accession
- 0001085146-23-001058
- Filer
- CIK 1791468
- Filed
- 2023-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 23 entries on the cover page, a total value of $375,461,657 stated on the cover page (in dollars after the unit check, H1), rows summing to $375,461,657 with VALUE read as dollars as filed, 13F file number 028-19612. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 923,800 | $101,618,000 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 3,169,892 | $61,274,012 | dollars as filed | |
| VECTIVBIO HLDG AG | H9060V101 | COM | 5,492,893 | $47,595,916 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 2,800,126 | $41,189,854 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 3,317,544 | $35,000,089 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 3,473,366 | $14,345,001 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 2,829,712 | $14,233,452 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 1,889,451 | $13,301,735 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 215,059 | $10,327,133 | dollars as filed | |
| OMEGA THERAPEUTICS INC | 68217N105 | COMMON STOCK | 1,055,882 | $6,029,085 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 726,109 | $4,770,536 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 1,637,372 | $4,355,409 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 3,549,820 | $4,224,286 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 333,252 | $3,122,571 | dollars as filed | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 7,987,396 | $2,963,323 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 2,204,876 | $2,315,120 | dollars as filed | |
| FREELINE THERAPEUTICS HLDGS | 35655L107 | SPONSORED ADS | 4,814,419 | $2,287,331 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 2,384,402 | $2,026,742 | dollars as filed | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 333,945 | $1,813,321 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 864,822 | $1,608,569 | dollars as filed | |
| ONCORUS INC | 68236R103 | COM | 2,367,436 | $599,672 | dollars as filed | |
| DIREXION SHS ETF TR | 25460G716 | DAILY S&P BIOTEC | 25,000 | $431,250 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 30,000 | $29,250 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-23-001058 | this filing | 2023-02-13 | acceptance time not in the bulk data set |